XKRX:950160 (USA)
Â
Korean Depository Receipts
â‚©
13880.00
(+3.27%)
Jul 5
Business Description
Kolon TissueGene Inc
NAICS : 325412
SIC : 2834
ISIN : KR8840120008
Share Class Description:
XKRX:950160: Korean Depository ReceiptsCompare
Compare
Traded in other countries / regions
950160.Korea IPO Date
2017-11-06Description
Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.84 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.42 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 22.46 | |||||
| Beneish M-Score | 5.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.9 | |||||
| 3-Year EBITDA Growth Rate | 30.8 | |||||
| 3-Year EPS without NRI Growth Rate | 29.5 | |||||
| 3-Year FCF Growth Rate | -15.4 | |||||
| 3-Year Book Growth Rate | 26.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.1 | |||||
| 9-Day RSI | 49.84 | |||||
| 14-Day RSI | 50.89 | |||||
| 6-1 Month Momentum % | 39.12 | |||||
| 12-1 Month Momentum % | 47.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.83 | |||||
| Quick Ratio | 0.83 | |||||
| Cash Ratio | 0.64 | |||||
| Days Inventory | 4.37 | |||||
| Days Sales Outstanding | 14.19 | |||||
| Days Payable | 28.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6 | |||||
| Shareholder Yield % | -3.55 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 11.2 | |||||
| Operating Margin % | -462.39 | |||||
| Net Margin % | -386.94 | |||||
| FCF Margin % | -1643.38 | |||||
| ROE % | -14.9 | |||||
| ROA % | -12.71 | |||||
| ROIC % | -22.31 | |||||
| ROC (Joel Greenblatt) % | -221.29 | |||||
| ROCE % | -13.83 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 228.46 | |||||
| PB Ratio | 8.86 | |||||
| Price-to-Tangible-Book | 122.9 | |||||
| EV-to-EBIT | -64.81 | |||||
| EV-to-EBITDA | -69.94 | |||||
| EV-to-Revenue | 245.24 | |||||
| EV-to-FCF | -14.92 | |||||
| Earnings Yield (Greenblatt) % | -1.54 | |||||
| FCF Yield % | -6.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kolon TissueGene Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 4,397.02 | ||
| EPS (TTM) (â‚©) | -236 | ||
| Beta | 0.46 | ||
| Volatility % | 50.53 | ||
| 14-Day RSI | 50.89 | ||
| 14-Day ATR (â‚©) | 685.151605 | ||
| 20-Day SMA (â‚©) | 14004.5 | ||
| 12-1 Month Momentum % | 47.35 | ||
| 52-Week Range (â‚©) | 7710 - 16900 | ||
| Shares Outstanding (Mil) | 78.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kolon TissueGene Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kolon TissueGene Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kolon TissueGene Inc Frequently Asked Questions
What is Kolon TissueGene Inc(XKRX:950160)'s stock price today?
The current price of XKRX:950160 is â‚©13880.00. The 52 week high of XKRX:950160 is â‚©16900.00 and 52 week low is â‚©7710.00.
When is next earnings date of Kolon TissueGene Inc(XKRX:950160)?
The next earnings date of Kolon TissueGene Inc(XKRX:950160) is .
Does Kolon TissueGene Inc(XKRX:950160) pay dividends? If so, how much?
Kolon TissueGene Inc(XKRX:950160) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers